Comment
doi: 10.1016/j.semarthrit.2020.03.022.
Epub 2020 May 5.
Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission
Affiliations
- PMID: 32504990
- DOI: 10.1016/j.semarthrit.2020.03.022
Item in Clipboard
Comment
Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission
Semin Arthritis Rheum.
2020 Aug.
No abstract available
Comment on
-
Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.Semin Arthritis Rheum. 2020 Apr;50(2):276-284. doi: 10.1016/j.semarthrit.2019.09.005. Epub 2019 Sep 19. Semin Arthritis Rheum. 2020. PMID: 31590930 Clinical Trial.
-
The patient global assessment in RA precludes the majority of patients otherwise in remission to reach this status in clinical practice. Should we continue to ignore this?Semin Arthritis Rheum. 2020 Aug;50(4):583-585. doi: 10.1016/j.semarthrit.2020.03.014. Epub 2020 May 19. Semin Arthritis Rheum. 2020. PMID: 32460149 No abstract available.
-
Attaining CDAI remission is the first gateway to attain Boolean remission.Semin Arthritis Rheum. 2020 Aug;50(4):624-626. doi: 10.1016/j.semarthrit.2020.05.006. Epub 2020 May 25. Semin Arthritis Rheum. 2020. PMID: 32502726 No abstract available.
Similar articles
-
Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.Semin Arthritis Rheum. 2020 Apr;50(2):276-284. doi: 10.1016/j.semarthrit.2019.09.005. Epub 2019 Sep 19. Semin Arthritis Rheum. 2020. PMID: 31590930 Clinical Trial.
-
Performances of Clinical Disease Activity Index (CDAI) and Simplified Disease Activity Index (SDAI) appear to be better than the gold standard Disease Assessment Score (DAS-28-CRP) to assess rheumatoid arthritis patients.Int J Rheum Dis. 2018 Nov;21(11):1933-1939. doi: 10.1111/1756-185X.13110. Epub 2017 Jun 12. Int J Rheum Dis. 2018. PMID: 28608433
-
Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants.Arthritis Rheum. 2011 Jan;63(1):43-52. doi: 10.1002/art.27740. Arthritis Rheum. 2011. PMID: 21204103 Clinical Trial.
-
Outcome assessments in rheumatoid arthritis.Curr Rheumatol Rep. 2013 Nov;15(11):370. doi: 10.1007/s11926-013-0370-y. Curr Rheumatol Rep. 2013. PMID: 24072601 Review.
-
ACR remission criteria and response criteria.Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-14-21. Clin Exp Rheumatol. 2006. PMID: 17083757 Review.
Cited by
-
Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An observational study.Reumatologia. 2022;60(2):81-91. doi: 10.5114/reum.2022.115987. Epub 2022 May 18. Reumatologia. 2022. PMID: 35782030 Free PMC article.
-
A Machine Learning Approach for Prediction of CDAI Remission with TNF Inhibitors: A Concept of Precision Medicine from the FIRST Registry.Rheumatol Ther. 2024 Jun;11(3):709-736. doi: 10.1007/s40744-024-00668-z. Epub 2024 Apr 18. Rheumatol Ther. 2024. PMID: 38637465 Free PMC article.
-
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis.Ther Adv Musculoskelet Dis. 2021 May 22;13:1759720X211011826. doi: 10.1177/1759720X211011826. eCollection 2021. Ther Adv Musculoskelet Dis. 2021. PMID: 34093745 Free PMC article.
-
Remote-Customized Telecontrol for Patients with Rheumatoid Arthritis: The iARPlus (Innovative Approach in Rheumatology) Initiative.J Pers Med. 2025 Jan 16;15(1):30. doi: 10.3390/jpm15010030. J Pers Med. 2025. PMID: 39852222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
